MEDSIR at #ESMO23

Download video

201 views

MEDSIR

1 year ago

MEDSIR at #ESMO23

1:19

MEDSIR at #ESMO23

by MEDSIR

4:38

Interview with Dr. Antonio Llombart - MEDSIR PHERGain's translational studies at ESMO23

by MEDSIR

2:38

All-Oral Myeloma Combo: Mezigdomide + Tazemetostat or Trametinib | Paul Richardson, MD | EHA 2025

by HealthTree University for Multiple Myeloma

25:30

Metabolic Reprogramming in Leptomeningeal Metastasis - Adrienne Boire, MD , PhD , FAAN

by Seattle Science Foundation

2:46

New Hope for MRD Recurrence? Daratumumab Proof-of-Concept Study | Krzysztof Jamroziak, MD | #EHA2025

by HealthTree University for Multiple Myeloma

1:35

MEDSIR - Connect, Innovate and Advance

by MEDSIR

2:12

MedJ at ESMO 2025

by MedJ

4:33

New Hope for Patients with Brain Metastases in HER2-Positive Breast Cancer

by MEDSIR

0:57

Can we avoid chemotherapy in low-risk HER2+ breast cancer patients?

by MEDSIR

3:33

Imlunestrant Uses, Dose and Side Effects | New Breast Cancer Medicine Explained

by Med Archive

1:27

What does MedSIR promote? CLINICAL RESEARCH

by MEDSIR

5:12

#MEDSIRatASCO - #TUXEDO3trial

by MEDSIR

$ER+\/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium$

5:32

ER+\/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium

by COR2ED The Heart of Medical Education

8:20

Metastasis - Routes, Types, Classic Sites, Classification, TNM

by MEDucation Made Easy

Best on Vidoe

MEDSIR at #ESMO23